Catherine Lewis
Family · Hardinsburg, KYNPI 1891238028
Payments from drug & device makers
Across 304 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$926
- AbbVie$713
- Bayer$408
- Biohaven Pharmaceutical Holding Company Ltd.$400
- Pfizer$375
- Amgen$368
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $926 |
| AbbVie | 47 | $713 |
| Bayer | 26 | $408 |
| Biohaven Pharmaceutical Holding Company Ltd. | 21 | $400 |
| Pfizer | 30 | $375 |
| Amgen | 25 | $368 |
| Biohaven Pharmaceuticals, Inc. | 16 | $210 |
| AstraZeneca | 12 | $192 |
| Novartis | 10 | $160 |
| Abiomed | 1 | $144 |
| Lilly USA, LLC | 10 | $142 |
| GSK | 9 | $126 |
| Johnson & Johnson | 3 | $91 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Astellas Pharma US Inc | 4 | $68 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Sunovion Pharmaceuticals Inc. | 3 | $42 |
| Exact Sciences | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Merck | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Shield Therapeutics Inc | 1 | $26 |
| Corcept Therapeutics | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$144
- Wegovy$120
- NURTEC ODT$111
- Mavyret$108
How this compares
$4,937 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 83 | $82,987 |
| OtezlaApremilast | 17 | $82,272 |
| JardianceEmpagliflozin | 105 | $79,554 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 106 | $73,355 |
| TrulicityDulaglutide | 52 | $65,674 |
| EliquisApixaban | 59 | $46,355 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $30,684 |
| XareltoRivaroxaban | 50 | $28,324 |
| VraylarCariprazine Hcl | 19 | $26,055 |
| JanuviaSitagliptin Phosphate | 22 | $21,800 |
| LinzessLinaclotide | 23 | $20,422 |
| FarxigaDapagliflozin Propanediol | 33 | $19,457 |
| MyrbetriqMirabegron | 34 | $17,638 |
| Nurtec OdtRimegepant Sulfate | 18 | $16,905 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $16,797 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $126 | $85,307132 claims |
| Novo NordiskOzempic | $926 | $82,98783 claims |
| AmgenOtezla | $368 | $82,27217 claims |
| Lilly USA, LLCTrulicity | $142 | $65,67452 claims |
| PfizerEliquis, Nurtec Odt | $375 | $63,26077 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere, Symbicort, Daliresp | $192 | $50,67099 claims |
| AbbVieVraylar, Linzess | $713 | $46,47742 claims |
| Johnson & JohnsonXarelto | $91 | $28,32450 claims |
| MerckJanuvia, Dulera | $33 | $25,39733 claims |
| Astellas Pharma US IncMyrbetriq | $68 | $17,63834 claims |
| BayerKerendia | $408 | $13,90320 claims |
| NovartisEntresto | $160 | $7,94312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Hardinsburg
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.